Parameter Recovery phase, survived ( ) Recovery phase, deceased ( ) valueOdds ratio Male 65,2% ( ) 64,7% ( ) 0,970 0,978 Female 34,8% ( ) 35,3% ( ) 0,970 1,023 Age 57,0 ± 13,9 ( ) 50,1 ± 16,7 ( ) 0,152 0,969 Days in the ICU 13,3 ± 13,5 ( ) 26,7 ± 21,6 ( ) 0,004 1,047 Duration prior to leukopenia 9,0 ± 15,8 ( ) 16,2 ± 17,3 ( ) 0,086 1,024 Respiratory frequency 25,7 ± 7,8 ( ) 27,4 ± 7,1 ( ) 0,243 1,031 First lactate (mg/dL) 21,0 ± 15,6 ( ) 29,0 ± 26,5 ( ) 0,368 1,02 APACHE II on admission 22,3 ± 7,8 ( ) 24,0 ± 9,9 ( ) 0,837 1,025 SOFA on admission 7,0 ± 4,7 ( ) 8,1 ± 5,2 ( ) 0,462 1,045 Intubation 39,1% ( ) 100% ( ) 0,000 53,919 Lowest oxygenation index 126,7 ± 94,2 ( ) 90,8 ± 45,3 ( ) 0,185 0,991 Tracheotomy 21,7% ( ) 64,7% ( ) 0,001 6,600 Lung failure after initial crisis 45,7% ( ) 94,1% ( ) 0,001 19,048 Vasopressors in the first 24 h 56,5% ( ) 82,4% ( ) 0,059 3,59 Maximal Noradrenaline dose (mg/h) 1,9 ± 1,6 ( ) 4,7 ± 4,2 ( ) 0,009 1,466 Fluid administration in the first 24 h (mL) 6670,7 ± 2375,0 ( ) 6819,5 ± 2977,2 ( ) 1,000 1 MAP first 24 h 56,0 ± 15,2 ( ) 56,6 ± 12,0 ( ) 0,643 1,003 Circulatory failure after initial crisis 4,3% ( ) 23,5% ( ) 0,021 6,769 Liver failure on admission 43,5% ( ) 41,2% ( ) 0,870 0,91 Lowest bilirubin 1,3 ± 1,2 ( ) 1,8 ± 2,6 ( ) 0,963 1,185 Lowest INR 1,2 ± 0,2 ( ) 1,2 ± 0,2 ( ) 0,871 0,792 Liver failure after initial crisis 37% ( ) 58,8% ( ) 0,120 2,437 Lowest urine output (mL/24 h) 1548,5 ± 1089,2 ( ) 640,5 ± 669,4 ( ) 0,001 0,999 Kidney failure 41,3% ( ) 82,4% ( ) 0,004 6,632 Renal replacement therapy 21,7% ( ) 64,7% ( ) 0,001 6,600 GCS on admission 12,7 ± 4,1 ( ) 12,8 ± 3,4 ( ) 0,871 1,005 GCS highest 15,0 ± 0,1 ( ) 13,7 ± 2,4 ( ) 0,000 0,070 Erythrocyte concentrates (units/day) 0,6 ± 1,2 ( ) 0,7 ± 0,5 ( ) 0,003 1,111 Platelet concentrates (units/day) 0,5 ± 0,7 ( ) 0,8 ± 0,5 ( ) 0,008 2,002 Fresh frozen plasma (units/day) 0,4 ± 0,9 ( ) 0,7 ± 0,6 ( ) 0,000 1,567 CRP highest in the first 10 days (mg/dL) 28,9 ± 8,8 ( ) 35,3 ± 11,5 ( ) 0,068 1,073 CRP lowest (mg/dL) 8,2 ± 6,5 ( ) 15,6 ± 11,4 ( ) 0,008 1,106 Persistent leukopenia 30,4% ( ) 52,9% ( ) 0,100 2,571